Outcomes of Participants With Diabetes in the ISCHEMIA Trials
Author(s) -
Jonathan Newman,
Rebecca Anthopolos,
G.B. John Mancini,
Sripal Bangalore,
Harmony R. Reynolds,
Dennis Kunichoff,
Roxy Senior,
Jesús Peteiro,
Balram Bhargava,
Pallav Garg,
Jorge Escobedo,
Rolf Doerr,
Tomasz Mazurek,
José Ramón González–Juanatey,
Grzegorz Gajos,
Carlo Briguori,
Hong Cheng,
András Vértes,
Sandeep Mahajan,
Luis A. Guzmán,
Matyàs Keltai,
Aldo P. Maggioni,
Gregg W. Stone,
Jeffrey S. Berger,
Yves Rosenberg,
William E. Boden,
Bernard R. Chaitman,
Jerome L. Fleg,
Judith S. Hochman,
David J. Maron
Publication year - 2021
Publication title -
circulation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 7.795
H-Index - 607
eISSN - 1524-4539
pISSN - 0009-7322
DOI - 10.1161/circulationaha.121.054439
Subject(s) - medicine , interquartile range , diabetes mellitus , hazard ratio , revascularization , kidney disease , myocardial infarction , coronary artery disease , cardiology , surgery , confidence interval , endocrinology
Among patients with diabetes and chronic coronary disease, it is unclear if invasive management improves outcomes when added to medical therapy.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom